Possible acceleration of regression by antibiotic treatment in benign cephalic histiocytosis with infiltration of CD11a/CD11c+ macrophages.
Quist
Sven R
SR
Weidling
Heike
H
Franke
Ingolf
I
Bonnekoh
Bernd
B
Gollnick
Harald P
HP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001706:Biopsy; D040881:CD11a Antigen / Q000032:analysis*; D039521:CD11c Antigen / Q000032:analysis*; D015616:Histiocytosis, Non-Langerhans-Cell / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007223:Infant; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology; D008297:Male; D012074:Remission Induction; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D040881:CD11a Antigen; D039521:CD11c Antigen